Abbott Laboratories (ABT)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 01:46PM EDT. Market open.
| Previous Close | 104.82 |
| Open | 103.96 |
| Bid | 104.62 x 900 |
| Ask | 104.59 x 900 |
| Day's Range | 103.44 - 104.91 |
| 52 Week Range | 89.67 - 121.64 |
| Volume | |
| Avg. Volume | 5,743,677 |
| Market Cap | 181.826B |
| Beta (5Y Monthly) | 0.75 |
| PE Ratio (TTM) | 32.56 |
| EPS (TTM) | 3.21 |
| Earnings Date | Jul 18, 2024 - Jul 22, 2024 |
| Forward Dividend & Yield | 2.20 (2.10%) |
| Ex-Dividend Date | Apr 12, 2024 |
| 1y Target Est | 125.80 |
ZacksWall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?
Based on the average brokerage recommendation (ABR), Abbott (ABT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ZacksHere's Why You Should Hold on to Abbott (ABT) Stock for Now
Abbott's (ABT) share recovery in the Nutrition business buoys optimism.
ZacksThe Zacks Analyst Blog Highlights Stocks recently featured in the blog include: UnitedHealth, Danaher, Abbott and Ark Restaurants
UnitedHealth, Danaher, Abbott and Ark Restaurants are included in this Analyst Blog.
© 2024 Yahoo. All rights reserved.